Tacrolimus, widely known as Prograf, has become the preferred immunosuppressant for preventing graft rejection in solid organ transplant recipients, particularly in steroid-sparing regimens. Its efficacy and reduced risk of acute and chronic rejection compared to cyclosporine have made it the prefer...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!